These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1086538)

  • 1. Transition from T cell protection to T cell enhancement during tumor growth in an allogeneic host.
    Manor Y; Treves AJ; Cohen IR; Feldman M
    Transplantation; 1976 Oct; 22(4):360-6. PubMed ID: 1086538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor factor secreted by T-lymphocytes from tumor-bearing mice.
    Treves AJ; Cohen IR; Feldman M
    J Natl Cancer Inst; 1976 Aug; 57(2):409-14. PubMed ID: 1087347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of the response of spleen cells from tumor-bearing animals in an in vivo tumor neutralization assay.
    Gabizon A; Small M; Trainin N
    Int J Cancer; 1976 Dec; 18(6):813-9. PubMed ID: 992909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stages.
    Yang YF; Zou JP; Mu J; Wijesuriya R; Ono S; Walunas T; Bluestone J; Fujiwara H; Hamaoka T
    Cancer Res; 1997 Sep; 57(18):4036-41. PubMed ID: 9307290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effect on tumor growth and antibody production.
    Isakov N; Segal S; Hollander N; Feldman M
    Int J Cancer; 1978 Oct; 22(4):465-70. PubMed ID: 359490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation.
    Treves AJ; Cohen IR; Feldman M
    Isr J Med Sci; 1976; 12(4-5):369-84. PubMed ID: 1084880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EnhancemenT of 3LL tumor growth by autosensitized t lymphocytes independent of the host lymphatic system.
    Carnaud C; Ilfeld D; Levo Y; Trainin N
    Int J Cancer; 1974 Aug; 14(2):168-75. PubMed ID: 4549211
    [No Abstract]   [Full Text] [Related]  

  • 8. Induced resistance in normal mice and growth enhancement in tumor-bearing mice by inoculation with syngeneic hybrid cells.
    Dei T; Tachibana T
    J Natl Cancer Inst; 1980 Oct; 65(4):739-49. PubMed ID: 6448309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell recruitment from the thymus to the spleen in tumor-bearing mice. II. Functional characteristics of recruited T-cells.
    Tanaka K; Koga Y; Taniguchi K; Kamikaseda K; Nihashi Y; Nomoto K
    J Natl Cancer Inst; 1986 Sep; 77(3):733-8. PubMed ID: 2943928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymosin modulation of suppressor function in mice and man.
    Serrou B; Rosenfeld C; Caraux J; Thierry C; Cupissol D; Goldstein A
    Ann N Y Acad Sci; 1979; 332():95-100. PubMed ID: 161154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of tumor-bearing state on the generation of in vivo protective immune T cells in a syngeneic murine tumor system.
    Fujiwara H; Hamaoka T; Nishino Y; Kitagawa M
    Gan; 1977 Oct; 68(5):589-601. PubMed ID: 73490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of immature cells from the thymus during solid tumor growth: identification by assay of TdT activity.
    Small M; Lasser-Weiss M; Daniel V
    J Immunol; 1979 Jul; 123(1):259-62. PubMed ID: 312875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against murine ascites tumours by lymphoid cell populations with T memory or cytotoxicity.
    Matter A; Askonas BA
    Transplantation; 1976 Aug; 22(2):184-9. PubMed ID: 1086016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells and T and B lymphocytes during tumor growth.
    Khaitov RM; Petrov RV; Gambarov SS; Norimov AS; Blinov VA
    Cell Immunol; 1976 Mar; 22(1):1-10. PubMed ID: 6150
    [No Abstract]   [Full Text] [Related]  

  • 16. [Defects in cell-mediated and humoral immunity in tumor-bearing mice. Evidence and characterization of suppressor cells ].
    Siegl E; Günther J; Schulze HA; Brock J
    Allerg Immunol (Leipz); 1981; 27(3):153-61. PubMed ID: 6214936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
    Kirchner H; Muchmore AV; Chused TM; Holden HT; Herberman RB
    J Immunol; 1975 Jan; 114(1 Pt 1):206-10. PubMed ID: 122986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
    Gjedde SB
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells.
    Tsuchiya Y; Igarashi M; Suzuki R; Kumagai K
    J Immunol; 1988 Jul; 141(2):699-708. PubMed ID: 2968407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.